mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.04 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.04 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.3 |
0.04 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.095 |
0.04 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.04 |